يتطور
صحة·2/6/2026ملخص الذكاء الاصطناعي
New Drug Spares Bladder Cancer Patients Life-Changing Surgery
An immunotherapy drug, durvalumab, combined with chemotherapy and radiotherapy, has shown promise in treating bladder cancer, potentially sparing patients radical surgery and preventing tumor recurrence. Results presented at a major cancer conference indicated an 85% success rate in a trial.
G
Guardian UK3 د قراءة